AI Articles and Analysis about Machine learning infrastructure

Machine learning is the subfield of computer science that gives computers the ability to learn without being explicitly programmed.

Header graphics – Sanofi-1-min

Artificial Intelligence at Sanofi

Sanofi is a global healthcare and pharmaceutical company. Founded in 1973, it aims to unlock and maximize the potential of critical medicines, vaccines, and self-care solutions for individuals. It accomplishes this across four global business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. 

01 – Confronting Unique Challenges in Retail and eCommerce Fraud@1x-min

Confronting Unique Challenges in Retail and eCommerce Fraud – with Leaders from Amazon, PayPal, FanDuel, and Riskified

This interview analysis is sponsored by Riskified and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

UNICRI on responsible AI criteria and other tool kits@2x-min

UNICRI-Approved Responsible AI Toolkits for Law Enforcement

The United Nations Interregional Crime and Justice Research Institute (UNICRI) was established in 1968 as an autonomous institution in response to a United Nations resolution urging expanded crime prevention and criminal justice activities. UNICRI's mission is to advance justice, crime prevention, security, and the rule of law to support peace, human rights, and sustainable development. 

AI at Takeda@1x-min

Artificial Intelligence at Takeda Pharmaceuticals

Takeda Pharmaceuticals is a 240-year-old, leading biopharmaceutical company headquartered in Tokyo, Japan, with a global hub in Cambridge, Massachusetts. The company has a global presence, operating in more than 80 countries across North America, Europe and Asia.

Generative AI Adoption Challenges From a Data Perspective – with Ted Kwartler of Data Robot and Tsavo Knott of Pieces@1x

Generative AI Adoption Challenges From a Data Perspective – with Ted Kwartler of Data Robot and Tsavo Knott of Pieces

This interview analysis is sponsored by Pieces and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Future of Drug Targeting – Lilly @2x-1-min

The Future of Drug Targeting and Clinical Development with Generative AI Tools – with Ramesh Durvasula of Eli Lilly

Lily is a pharmaceutical giant with a legacy dating back to its founding in 1876 by Colonel Eli Lilly. The company engages more than 9600 employees in research and development, with clinical research conducted in more than 55 countries. As of 2022, the company clocked a revenue of $28,541.4 million and made a net income of $6,244.8 million. 

AI at GSK@2x-min

Artificial Intelligence at GSK

GlaxoSmithKline (GSK) is a multinational pharmaceutical company headquartered in Brentford, UK. The company operates in over 150 countries. GSK offers a wide range of pharmaceutical products, vaccines, and consumer healthcare products, including over-the-counter medications, oral care and nutritional products.

AI at Cardinal Health@2x-min

Artificial Intelligence at Cardinal Health – Two Use Cases

Cardinal Health is a global healthcare services company with a rich history and a strong focus on providing integrated solutions to the healthcare industry. Established in 1971, the company has become a leading player in the healthcare sector, offering a wide range of products, services, and technologies to enhance patient care, optimize supply chain efficiency, and drive value-based outcomes.

Machine learning infrastructure

Machine learning is the subfield of computer science that gives computers the ability to learn without being explicitly programmed.